Associate Professor, Marketing Department, W. P. Carey School of Business, 2010-present
Ph.D., Economics, The Wharton School, University of Pennsylvania, 2001; B.A., Economics, Baylor University, 1997
Physician organizations; physician incentives and learning; prescription drugs and medical devices; hospital competition under managed care.
Pfizer, Inc.; Wollters Kluwer Health
Physician-hospital gainsharing; physicians decisionmamking; diffusion of drug-eluting stents; Medicare Part D
Academic Positions Held
Associate Professor, Department of Marketing, W. P. Carey School of Business, Arizona State University: 2010-present; Assistant Professor, School of Health Management and Policy, W. P. Carey School of Business, 2005-2010; Visiting Scholar, Robert Wood Johnson Foundation Scholars in Health Policy Research Program, University of California, Berkeley and UCSF.
Career and Recent Professional Awards; Teaching Awards
NIHCM Foundation's Nineteenth Annual Health Care Research Award winner, 2013; Faculty Achievement Award, Defining Edge Research and Creative Work, Best Professional Application (ASU university-wide award), 2013; John D. Thompson Prize for Young Investigators. Awarded by the Association of University Programs in Health Administration, 2010
Jonathan Ketcham, Claudio Lucarelli, Eugenio Miravete and M. Christopher Roebuck. 2012. “Sinking, Swimming, or Learning to Swim in Medicare Part D?” American Economic Review, 102(6): 2639-2673.
Andrew Epstein, Jonathan Ketcham, Saif Rathore and Peter Groeneveld. 2012. “Variations in Access to Innovation by Payer: The Case of Drug-Eluting Stents.” Medical Care, 50(1): 1-9.
Andrew Epstein, Jonathan Ketcham, and Sean Nicholson. 2010. “Specialization and Matching in Professional Firms.” RAND Journal of Economics, 41(4): 812–835.
Saif Rathore, Jonathan Ketcham, G. Caleb Alexander, and Andrew Epstein. 2009. “Influence of Patient Race on Physician Prescribing Decisions: A Randomized On-line Experiment.” Journal of General Internal Medicine, 24(11): 1183-91.
Jonathan Ketcham, Karen Lutfey, Eric Gerstenberger, Carol Link and John McKinlay. 2009. “Physician Clinical Information Technology and Health Care Disparities.” Medical Care Research and Review, 66(6): 658-681.
Jonathan Ketcham and Kosali Simon. 2008. “Medicare Part D's Effects on Elderly Drug Costs and Utilization.” American Journal of Managed Care, 14(11): SP14-22. Previously NBER working paper #14326.
Jonathan Ketcham and Jeffrey Ngai. 2008. “How Similar are States’ Medicaid Preferred Drug Lists?” American Journal of Managed Care, 14(11): SP46-52.
Andrew Epstein, Saif Rathore, G. Caleb Alexander, and Jonathan Ketcham. 2008. “Primary Care Physicians’ Views on Medicare Part D.” American Journal of Managed Care, 14(11): SP5-13.
Jonathan Ketcham and Michael Furukawa. 2008. “Hospital-Physician Gainsharing in Cardiology.” Health Affairs 27(3): 803-812.
Glenn Melnick and Jonathan Ketcham. 2008. “Have HMOs Broadened their Hospital Networks: Changes in HMO Hospital Networks in California, 1999-2003.” Medical Care 46(3): 339-342.
Jonathan Ketcham and Andrew Epstein. 2008. “Medicaid Preferred Drug Lists’ Costs to Physicians.” Medical Care 46(1): 9-16.
Michael Furukawa, Jonathan Ketcham and Mary Rimsza. 2007. “Physician Practice Revenues and Use of Information Technology in Patient Care.” Medical Care. 45(2): 168-176.
Jonathan Ketcham, Laurence Baker, and Donna MacIsaac. 2007. “Physician practice size and variations in treatments and outcomes: Evidence from Medicare patients with acute myocardial infarction.” Health Affairs. 26(1): 195-205.
ASU is a tier 1 research university and W. P. Carey is proud of its strong tradition of teaching and classroom excellence. Our students directly benefit from the research and theories our faculty brings into the classroom. Below is a list of courses being taught during the current semester by this faculty member. Click a course to view it in the ASU course catalog.
MKT 352 - Marketing Research
Knowledge and skills to make intelligent decisions in the design, evaluation and application of marketing research and market data.